374 Patient-reported outcomes in breast cancer patients undergoing endocrine therapy (PRO-BETh): impact of CYP2D6 genotype and side-effects on adherence rates
M. HubalekVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70400-6
File:
PDF, 45 KB
english, 2010